At the dated check, the references listed below either did not resolve in
Crossref or DataCite, or carried a retraction notice. Each one is shown with the
registry record that put it there.
The 91 checked references that resolve
resolves10.1177/000313489906500106Cells Isolated from Adult Human Skeletal Muscle Capable of Differentiating into Multiple Mesodermal Phenotypes
resolves10.1038/sj.bmt.1705358Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads
resolves10.1073/pnas.240309797Postnatal human dental pulp stem cells (DPSCs)
<i>in vitro</i>
and
<i>in</i>
<i>vivo</i>
resolves10.1186/1471-213x-7-11Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro
resolves10.1016/j.mad.2007.12.002Age-related changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapies
resolves10.1016/j.bone.2003.07.005Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells,
resolves10.1038/srep07144Aging disrupts cell subpopulation dynamics and diminishes the function of mesenchymal stem cells
resolves10.1089/scd.2013.0231Age-Related Decreases of
<i>Serum-Response Factor</i>
Levels in Human Mesenchymal Stem Cells Are Involved in Skeletal Muscle Differentiation and Engraftment Capacity
resolves10.1002/stem.1709Inhibition of Akt/mTOR Attenuates Age-Related Changes in Mesenchymal Stem Cells
resolves10.1164/rccm.201306-1043ocAging Mesenchymal Stem Cells Fail to Protect Because of Impaired Migration and Antiinflammatory Response
resolves10.3389/fnagi.2014.00103SIRT1 ameliorates age-related senescence of mesenchymal stem cells via modulating telomere shelterin
resolves10.1371/journal.pone.0111850Aging Increases the Susceptivity of MSCs to Reactive Oxygen Species and Impairs Their Therapeutic Potency for Myocardial Infarction
resolves10.1089/rej.2009.0986The Effect of Age on the Efficacy of Human Mesenchymal Stem Cell Transplantation after a Myocardial Infarction
resolves10.3109/14653240903313941Age-dependent neuroectodermal differentiation capacity of human mesenchymal stromal cells: limitations for autologous cell replacement strategies
resolves10.1042/CBI20090211Effects of non-steroidal anti-inflammatory drugs on proliferation, differentiation and migration in equine mesenchymal stem cells
resolves10.1089/ten.tea.2012.0129Effect of Acetaminophen and Nonsteroidal Anti-Inflammatory Drugs on Gene Expression of Mesenchymal Stem Cells
resolves10.1186/ar4614Naproxen affects osteogenesis of human mesenchymal stem cells via regulation of Indian hedgehog signaling molecules
resolves10.1111/j.1582-4934.2010.01006.xNSAIDS inhibit in vitro MSC chondrogenesis but not osteogenesis: implications for mechanism of bone formation inhibition in man
resolves10.4236/ojemd.2013.33027High-Fat Diets-Induced Metabolic Alterations Alter the Differentiation Potential of Adipose Tissue-Derived Stem Cells
resolves10.1096/fj.10-171439Obesity short‐circuits stemness gene network in human adipose multipotent stem cells
resolves10.1038/ijo.2012.171Diet-induced obesity alters the differentiation potential of stem cells isolated from bone marrow, adipose tissue and infrapatellar fat pad: the effects of free fatty acids
resolves10.1186/1471-2164-14-625Stem cells isolated from adipose tissue of obese patients show changes in their transcriptomic profile that indicate loss in stemcellness and increased commitment to an adipocyte-like phenotype
resolves10.1900/rds.2009.6.260Mesenchymal Stem Cells Derived from Bone Marrow of Diabetic Patients Portrait Unique Markers Influenced by the Diabetic Microenvironment
resolves10.1186/scrt468Diabetes impairs the angiogenic potential of adipose-derived stem cells by selectively depleting cellular subpopulations
resolves10.1002/cbf.3056Characterization of human adipose tissue‐derived stromal cells isolated from diabetic patient's distal limbs with critical ischemia
resolves10.1634/stemcells.2005-0330Human Umbilical Cord Matrix Stem Cells: Preliminary Characterization and Effect of Transplantation in a Rodent Model of Parkinson's Disease
resolves10.1186/scrt442Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton’s jelly
resolves10.1007/s11626-011-9480-xComparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton’s jelly
resolves10.1155/2013/428726Comparison of Explant-Derived and Enzymatic Digestion-Derived MSCs and the Growth Factors from Wharton’s Jelly
resolves10.1006/bbrc.2001.5777Retention of Multilineage Differentiation Potential of Mesenchymal Cells during Proliferation in Response to FGF
resolves10.1182/blood-2007-07-103697PDGF, TGF-β, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages
resolves10.1002/jcp.20238FGF‐2 enhances the mitotic and chondrogenic potentials of human adult bone marrow‐derived mesenchymal stem cells
resolves10.4061/2011/235176Fibroblast Growth Factor-2 Enhances Expansion of Human Bone Marrow-Derived Mesenchymal Stromal Cells without Diminishing Their Immunosuppressive Potential
resolves10.1371/journal.pone.0110764Umbilical Cord Wharton’s Jelly Repeated Culture System: A New Device and Method for Obtaining Abundant Mesenchymal Stem Cells for Bone Tissue Engineering
resolves10.1007/s10561-014-9425-1Comparison of human mesenchymal stem cells isolated by explant culture method from entire umbilical cord and Wharton’s jelly matrix
resolves10.1007/s00418-008-0519-3Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers
resolves10.1089/scd.2010.0260A Rapid, Simple, and Reproducible Method for the Isolation of Mesenchymal Stromal Cells from Wharton's Jelly Without Enzymatic Treatment
resolves10.1080/14653240600855905Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
resolves10.2174/1875043501104010006Phenotype and Differentiation Potential of Stromal Populations Obtained from Various Zones of Human Umbilical Cord: An Overview
resolves10.1089/scd.2009.0299New Emerging Potentials for Human Wharton’s Jelly Mesenchymal Stem Cells: Immunological Features and Hepatocyte-Like Differentiative Capacity
resolves10.2217/rme.09.12Novel Sources of Fetal Stem Cells: Where do they Fit on the Developmental Continuum?
resolves10.1016/j.scr.2010.08.005Optimization and scale-up of Wharton's jelly-derived mesenchymal stem cells for clinical applications
resolves10.1042/CBI20100326Generation of mesenchymal stem cell from human umbilical cord tissue using a combination enzymatic and mechanical disassociation method
resolves10.1007/s12015-010-9166-xHuman Wharton’s Jelly Stem Cells Have Unique Transcriptome Profiles Compared to Human Embryonic Stem Cells and Other Mesenchymal Stem Cells
resolves10.1038/sj.cgt.7701077Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors
resolves10.3390/ijms140611692Wharton’s Jelly-Derived Mesenchymal Stem Cells: Phenotypic Characterization and Optimizing Their Therapeutic Potential for Clinical Applications
resolves10.1002/jcb.24073Human umbilical cord wharton's jelly stem cell (hWJSC) extracts inhibit cancer cell growth in vitro
resolves10.1002/jcb.24724Human Keloid Cell Characterization and Inhibition of Growth with Human Wharton's Jelly Stem Cell Extracts
resolves10.1371/journal.pone.0061366Microvesicles Derived from Human Umbilical Cord Wharton’s Jelly Mesenchymal Stem Cells Attenuate Bladder Tumor Cell Growth In Vitro and In Vivo
resolves10.1007/s12015-014-9514-3Human Wharton's Jelly Stem Cells, its Conditioned Medium and Cell-Free Lysate Inhibit the Growth of Human Lymphoma Cells
resolves10.1016/j.lungcan.2010.01.003Human umbilical cord matrix-derived stem cells expressing interferon-β gene significantly attenuate bronchioloalveolar carcinoma xenografts in SCID mice
resolves10.3109/14653240903548194Cytotherapy with naive rat umbilical cord matrix stem cells significantly attenuates growth of murine pancreatic cancer cells and increases survival in syngeneic mice
resolves10.1016/j.canlet.2009.02.011Naïve human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivo
resolves10.1002/jcb.24367Human Wharton's Jelly stem cell conditioned medium and cell‐free lysate inhibit human osteosarcoma and mammary carcinoma cell growth in vitro and in xenograft mice
resolves10.1186/1471-2407-10-590Therapy with un-engineered naïve rat umbilical cord matrix stem cells markedly inhibits growth of murine lung adenocarcinoma
resolves10.1158/0008-5472.CAN-08-2750Rat Umbilical Cord Stem Cells Completely Abolish Rat Mammary Carcinomas with No Evidence of Metastasis or Recurrence 100 Days Post–Tumor Cell Inoculation
resolves10.1186/s12935-014-0093-9Human umbilical cord mesenchymal stem cells promote carcinoma growth and lymph node metastasis when co-injected with esophageal carcinoma cells in nude mice
resolves10.1371/journal.pone.0096836Microvesicles Derived from Human Wharton's Jelly Mesenchymal Stem Cells Promote Human Renal Cancer Cell Growth and Aggressiveness through Induction of Hepatocyte Growth Factor
resolves10.1016/j.cellimm.2011.09.010Immunomodulatory effect of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells on lymphocytes
resolves10.2174/1875043501104010028Wharton's Jelly Mesenchymal Stem Cells as Off-The-Shelf Cellular Therapeutics: A Closer Look into their Regenerative and Immunomodulatory Properties
resolves10.1161/CIRCULATIONAHA.110.955971Differentiation of Allogeneic Mesenchymal Stem Cells Induces Immunogenicity and Limits Their Long-Term Benefits for Myocardial Repair
resolves10.3727/096368908786092793In Vivo Survival and Osteogenic Differentiation of Allogeneic Rat Bone Marrow Mesenchymal Stem Cells (MSCs)
resolves10.1016/j.cellimm.2012.06.010Immune characterization of mesenchymal stem cells in human umbilical cord Wharton’s jelly and derived cartilage cells
resolves10.1507/endocrj.EJ12-0343Long term effects of the implantation of Wharton’s jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus
resolves10.1186/scrt446A preliminary evaluation of efficacy and safety of Wharton’s jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus
resolves10.1002/jbmr.1851DNA damage drives accelerated bone aging via an NF-<b>κ</b>B–dependent mechanism
resolves10.1186/1741-7015-11-146Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells
resolves10.1186/ar4520Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study
resolves10.1159/000362530Mesenchymal Stromal Cells as an Adjuvant Treatment for Severe Late-Onset Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
checked 2026-07-23 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.